542 related articles for article (PubMed ID: 28857066)
1. Hypoparathyroidism.
Mannstadt M; Bilezikian JP; Thakker RV; Hannan FM; Clarke BL; Rejnmark L; Mitchell DM; Vokes TJ; Winer KK; Shoback DM
Nat Rev Dis Primers; 2017 Aug; 3():17055. PubMed ID: 28857066
[TBL] [Abstract][Full Text] [Related]
2. Hypoparathyroidism.
Al-Azem H; Khan AA
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
[TBL] [Abstract][Full Text] [Related]
3. Management of Hypoparathyroidism: Present and Future.
Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
[TBL] [Abstract][Full Text] [Related]
4. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
[TBL] [Abstract][Full Text] [Related]
5. Hypoparathyroidism - disease update and emerging treatments.
Monis EL; Mannstadt M
Ann Endocrinol (Paris); 2015 May; 76(2):84-8. PubMed ID: 25882889
[TBL] [Abstract][Full Text] [Related]
6. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
[TBL] [Abstract][Full Text] [Related]
7. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.
Marcucci G; Della Pepa G; Brandi ML
Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
9. Hypocalcemic disorders.
Bove-Fenderson E; Mannstadt M
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):639-656. PubMed ID: 30449546
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism.
Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W
Bone; 2021 Mar; 144():115834. PubMed ID: 33359892
[TBL] [Abstract][Full Text] [Related]
11. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
Walker Harris V; Jan De Beur S
Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
[TBL] [Abstract][Full Text] [Related]
12. [Hypoparathyroidism - un underestimated problem?].
Petersenn S; Bojunga J; Brabant G; Etzrodt-Walter G; Finke R; Scharla S; Stamm B; Weber MM; Wicke C; Siggelkow H
MMW Fortschr Med; 2019 Dec; 161(Suppl 7):12-20. PubMed ID: 31828671
[TBL] [Abstract][Full Text] [Related]
13. [Hypoparathyroidism: the present state of art].
Krysiak R; Handzlik-Orlik G; Kedzia A; Machnik G; Okopień B
Wiad Lek; 2013; 66(1):18-29. PubMed ID: 23905424
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
[TBL] [Abstract][Full Text] [Related]
15. Hypoparathyroidism and the Kidney.
Peacock M
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):839-853. PubMed ID: 30390817
[TBL] [Abstract][Full Text] [Related]
16. [Recombinant human parathyroid hormone in the therapy of hypoparathyroidism].
Eremkina AK; Mokrysheva NG; Kovaleva EV; Krupinova YA
Ter Arkh; 2017; 89(10):80-86. PubMed ID: 29171476
[TBL] [Abstract][Full Text] [Related]
17. Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption.
Saraff V; Rothenbuhler A; Högler W; Linglart A
Horm Res Paediatr; 2018; 89(4):271-277. PubMed ID: 28926829
[TBL] [Abstract][Full Text] [Related]
18. Hypoparathyroidism.
Hakami Y; Khan A
Front Horm Res; 2019; 51():109-126. PubMed ID: 30641528
[TBL] [Abstract][Full Text] [Related]
19. Hypoparathyroidism and pseudohypoparathyroidism.
Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
[TBL] [Abstract][Full Text] [Related]
20. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L;
J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
